Ankylosing Spondylitis

Diagnosis and management of axial spondyloarthritis.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)

Last reviewed: 21 October 2025

Rheumatology

Clinical Guidelines

2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis

BSR and BHPR guideline for the treatment of axial spondyloarthritis

CKS: Axial spondyloarthritis (including ankylosing spondylitis)

NICE guideline [NG100]

NICE guideline [NG65]: Spondyloarthritis

NICE technology appraisal guidance [TA383]: TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis

2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

ASAS-EULAR recommendations for the management of axial spondyloarthritis, including ankylosing spondylitis and non-radiographic axial spondyloarthritis: 2022 update

First update of the international ASAS consensus statement for the use of anti‐TNF agents in patients with ankylosing spondylitis